Literature DB >> 17433969

Positron emission tomography in oncology: a review.

K A Wood1, P J Hoskin, M I Saunders.   

Abstract

Positron emission tomography is an evolving imaging tool that is becoming increasingly available for use in clinical practice. This overview will look at the current evidence for the use of positron emission tomography in imaging different tumour types and the different radiotracers that are either available or being evaluated in an investigational setting.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17433969     DOI： 10.1016/j.clon.2007.02.001

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


  17 in total

1.  Study of an image-derived SUV and a modified SUV using mouse FDG-PET.

Authors:  Xiujuan Zheng; Chin-Lung Yu; Wei Sha; Caius Radu; Sung-Cheng Huang; Dagan Feng
Journal:  Nucl Med Biol       Date:  2010-12-03       Impact factor: 2.408

2.  The use of PET/CT in evaluating disease recurrence following Ewing's tumour resection of the chest wall.

Authors:  Shayanthan Nanthakumaran; Imran Inam; Veronica Neefjes; Christopher P Driver; George G Youngson
Journal:  Pediatr Surg Int       Date:  2007-11-06       Impact factor: 1.827

3.  Broadening the scope of image-guided radiotherapy (IGRT).

Authors:  Carlo Greco; C Clifton Ling
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

Review 4.  Probing carbohydrate metabolism using hyperpolarized 13 C-labeled molecules.

Authors:  Jaspal Singh; Eul Hyun Suh; Gaurav Sharma; Chalermchai Khemtong; A Dean Sherry; Zoltan Kovacs
Journal:  NMR Biomed       Date:  2018-11-26       Impact factor: 4.044

Review 5.  Predicting outcomes in radiation oncology--multifactorial decision support systems.

Authors:  Philippe Lambin; Ruud G P M van Stiphout; Maud H W Starmans; Emmanuel Rios-Velazquez; Georgi Nalbantov; Hugo J W L Aerts; Erik Roelofs; Wouter van Elmpt; Paul C Boutros; Pierluigi Granone; Vincenzo Valentini; Adrian C Begg; Dirk De Ruysscher; Andre Dekker
Journal:  Nat Rev Clin Oncol       Date:  2012-11-20       Impact factor: 66.675

6.  Solid-phase synthesis and fluorine-18 radiolabeling of cycloRGDyK.

Authors:  Ryan A Davis; Kevin Lau; Sven H Hausner; Julie L Sutcliffe
Journal:  Org Biomol Chem       Date:  2016-09-21       Impact factor: 3.876

7.  Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography.

Authors:  Jennifer M Murphy; Amanda L Armijo; Julian Nomme; Chi Hang Lee; Quentin A Smith; Zheng Li; Dean O Campbell; Hsiang-I Liao; David A Nathanson; Wayne R Austin; Jason T Lee; Ryan Darvish; Liu Wei; Jue Wang; Ying Su; Robert Damoiseaux; Saman Sadeghi; Michael E Phelps; Harvey R Herschman; Johannes Czernin; Anastassia N Alexandrova; Michael E Jung; Arnon Lavie; Caius G Radu
Journal:  J Med Chem       Date:  2013-08-15       Impact factor: 7.446

8.  CEST MRI of 3-O-methyl-D-glucose uptake and accumulation in brain tumors.

Authors:  Akansha Ashvani Sehgal; Yuguo Li; Bachchu Lal; Nirbhay N Yadav; Xiang Xu; Jiadi Xu; John Laterra; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2018-09-11       Impact factor: 4.668

Review 9.  Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.

Authors:  Gigin Lin; Yuen-Li Chung
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

10.  Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas.

Authors:  R K Ramanathan; D Goldstein; R L Korn; F Arena; M Moore; S Siena; L Teixeira; J Tabernero; J-L Van Laethem; H Liu; D McGovern; B Lu; D D Von Hoff
Journal:  Ann Oncol       Date:  2016-01-22       Impact factor: 32.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.